EGAD00001000703 |
SCLC - Whole genome sequencing data
Publication Peifer et al., 2012, Nature Genetics |
Illumina Genome Analyzer IIx |
29 |
EGAD00001000716 |
RNAseq data, Publication Fernandez-Cuesta et al., 2014, CD74-NRG1 fusions in lung adenocarcinoma |
Illumina HiSeq 2000 |
25 |
EGAD00001000746 |
Fernandez-Cuesta et al., RNAseq data Pipline |
Illumina HiSeq 2000 |
25 |
EGAD00001000795 |
Fernandez-Cuesta et al, 2014, Nature Communication, RNA Sequencing data set |
Illumina HiSeq 2000 |
69 |
EGAD00001000813 |
Fernandez-Cuesta et al., 2014, Nature Communication,
Whole genome sequencing was performed using a read length of 2x100 bp for all
samples. On average, 110 Gb of sequence were produced per sample, aiming a
mean coverage of 30x for both tumour and matched normal. |
Illumina HiSeq 2000 |
29 |
EGAD00001000820 |
Fernandez-Cuesta et al, 2014, Nature Communication, Whole exome sequencing data set |
Illumina HiSeq 2000 |
15 |
EGAD00001000977 |
WGS dataset LCNEC study |
Illumina HiSeq 2000 |
11 |
EGAD00001001244 |
RNA-sequencing (RNA-seq) was performed with RNA extracted from fresh-frozen
human tumor tissue samples. cDNA libraries were prepared from poly-A selected
RNA applying the Illumina TruSeq protocol for mRNA. The libraries were then
sequenced with a 2 x 100bp paired-end protocol to a minimum mean coverage of 30x
of the annotated transcriptome. |
Illumina HiSeq 2000 |
59 |
EGAD00001001273 |
Whole genome sequencing was performed with DNA extracted from fresh-frozen
tumor and normal material. Short insert DNA libraries were prepared with the TruSeq
DNA PCRfree sample preparation kit (Illumina) for paired-end sequencing at a
minimum read length of 2x100bp. Human DNA libraries were sequenced to an
average coverage of minimum 30x for both tumor and matched normal. Murine DNA
libraries of tumor and matched normal were both sequenced to a coverage of 25x. |
Illumina HiSeq 2000 |
100 |
EGAD00001001431 |
SCLC - RNA sequencing data Publication Peifer et al., 2012, Nature Genetics |
Illumina HiSeq 2000 |
15 |
EGAD00001003099 |
RNAseq data set (Mollaoglu et al., MYC drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to Aurora kinase inhibition)
RNA isolation from primary tumors and healthy lungs was performed using RNeasy Mini Kit (Qiagen) with the standard protocol. RNA was subjected to library construction with the Illumina TruSeq Stranded mRNA Sample Preparation Kit (cat# RS-122-2101, RS-122-2102) according to manufacturer’s protocol. Chemically denatured sequencing libraries (25 pM) are applied to an Illumina HiSeq v4 single read flow cell using an Illumina cBot. Hybridized molecules were clonally amplified and annealed to sequencing primers with reagents from an Illumina HiSeq SR Cluster Kit v4-cBot (GD-401-4001). Following transfer of the flowcell to an Illumina HiSeq 2500 instrument (HCSv2.2.38 and RTA v1.18.61), a 50 cycle single-read sequence run was performed using HiSeq SBS Kit v4 sequencing reagents (FC-401-4002). |
Illumina HiSeq 2000 |
14 |
EGAD00001003316 |
RNAseq of LC2AD with AD80 or DMSO
Plenker et al., Mechanistic insight into RET kinase inhibitors targeting the DFG-out conformation in RET-rearranged cancer |
Illumina HiSeq 2000 |
1 |
EGAD00001003464 |
For RNA-Seq total RNA was isolated following LDC67 or JQ1 treatment. 3’RNAseq libraries were prepared with QUANT SEQ FWD 3´mRNA-Seq Kit (Lexogen, Austria), sequenced on an Illumina HiSeq 4000 |
Illumina HiSeq 2000 |
3 |
EGAD00001003801 |
RNAseq Data set |
Illumina HiSeq 2000 |
40 |
EGAD00001003815 |
Whole exome sequencing |
Illumina HiSeq 2000 |
48 |
EGAD00001003969 |
RNA-seq analyses were performed on cDNA libraries prepared from PolyA+ RNA using the Illumina TruSeq protocol for mRNA. The final libraries were sequenced with a paired-end 2×75 bp protocol aiming at 8.5 Gb per sample for a 30x mean coverage of the annotated transcriptome. All sequencing reactions were conducted on an Illumina HiSeq instrument (Illumina, San Diego, CA, USA). |
Illumina HiSeq 2000 |
7 |
EGAD00001003970 |
For whole-exome sequencing 1 µg of DNA from fresh-frozen tumors was fragmented by sonication technology (for DNA from fresh-frozen tumors: Bioruptor, diagenode, Liѐge, Belgium; for DNA from FFPE material: Covaris). The fragments were end-repaired and adaptor-ligated, including incorporation of sample index barcodes. After size selection, libraries were subjected to an enrichment process with Sure select XT (Agilent). The final libraries were sequenced with a paired-end 2×75 bp protocol for an average coverage of 100-120x |
Illumina HiSeq 2000 |
7 |
EGAD00010000526 |
SNP 6.0 arrays of small cell lung cancer |
Affymetrics_SNP_6.0- |
63 |
EGAD00010000546 |
SNP 6.0 arrays of carcinoid samples |
Affymetrics_SNP_6.0- |
74 |
EGAD00010000554 |
SNP 6.0 arrays of small cell lung cancer |
|
1032 |
EGAD00010000556 |
SNP 6.0 arrays of small cell lung cancer |
|
1 |
EGAD00010000558 |
SNP 6.0 arrays of small cell lung cancer |
Affymetrix SNP 6.0 |
54 |
EGAD00010001511 |
SNP 6.0 arrays of LCNEC samples |
Affymetrix SNP 6.0 |
54 |